Leyden Labs
- Health & Biotech
- Leiden, NL
- Private
- leydenlabs.com
Leiden-based biotech developing intranasal protection against respiratory viruses; its June 2026 EUR 40M round drew Invest-NL, EIC and the Gates Foundation.
$46.4MEquity raised in 2025–20262025 — · 2026 $46.4M · 1 equity round
$46.4MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed
Rounds over time log-scaled amounts
Funding history 1 round · 1 source
Earlier rounds not yet sourced. Leyden Labs raised before 25 Jun 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.
- Funding round (investor consortium)Amount$46.4MEUR 40MPost-money—✓ Confirmed
- Earlier rounds not yet sourced
Investors 4
- ClavystBio
- EIC Fund
- Gates Foundation Strategic Investment Fund
- Invest-NL
Highlighted investors led at least one equity round; the number is equity rounds taken part in.
Related companies shared investors
Axelera AIAI Infra · $317M in 2025–2026Shared: Invest-NL, EIC FundVitestroHealth · $70M in 2025–2026Shared: Invest-NL, EIC FundMorphotonicsDeep Tech · $44.1M in 2025–2026Shared: Invest-NL, EIC FundMultiverse ComputingAI Infra · $785M in 2025–2026Shared: EIC FundProxima FusionEnergy · $618M in 2025–2026Shared: EIC FundCuspAIDeep Tech · $550M in 2025–2026Shared: Invest-NL
Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Leyden Labs and its logo are trademarks of their owners, used here for identification only.
